ABK Biomedical raises $35 million USD to bring liver cancer treatment to market
Series D funding will support commercialization of Halifax company's Eye90 microspheres. Halifax-based ABK Biomedical has raised $35 million USD ($49.1...
Bring
As liver cancer rates surge, advances in treatment bring hope
By Emily Gaines Buchler / Published Sept 16, 2025 Margot got the news in her early 20s: "You have liver...
